Synthetech, Inc. 

(Public, OTC:NZYM)   Watch this stock   
Find more results for NZYM
Nov 10, 2009
Q2 2010 Conference Call
Nov 10, 2009
Q2 2010 Release
  

Key stats and ratios

Q2 (Jun '09) 2009
Net profit margin 20.78% 5.79%
Operating margin 21.57% 6.59%
EBITD margin - 9.10%
Return on average assets 29.29% 9.16%
Return on average equity 38.50% 12.81%
Employees 75 -

Address

1290 Industrial Way PO Box 646
Albany, OR 97321
United States - Map
+1-541-9676575 (Phone)
+1-541-9679424 (Fax)

Website links

Synthetech, Inc. discussions

  View all discussions »

Description

Synthetech, Inc. is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. Synthetech develops and manufactures custom chiral intermediates, amino acid derivatives, specialty amino acids, peptide fragments and specialty resins. The Company’s products are used in the development and manufacture of therapeutic peptides and peptidomimetic (peptide-like) and small molecule drugs in clinical studies and commercial applications.

Officers and directors

Daniel T. Fagan Ph.D.
Chairman of the Board
Age: 57
Gregory R. Hahn Ph.D.
President, Chief Executive Officer, Director
Age: 53
Gary A. Weber
Chief Financial Officer, Vice President - Finance and Administration, Treasurer, Secretary
Age: 51
Frederic Farkas
Vice President - Operations
Age: 48
Brett S. Reynolds
Vice President - Sales and Marketing
Age: 37
Charles B. Williams
Director
Age: 62
Paul C. Ahrens
Director
Age: 57
Howard L. Farkas
Director
Age: 84
Donald E. Kuhla Ph.D.
Director
Age: 66
Hans C. Noetzli
Director
Age: 68